GB0814990D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0814990D0
GB0814990D0 GBGB0814990.8A GB0814990A GB0814990D0 GB 0814990 D0 GB0814990 D0 GB 0814990D0 GB 0814990 A GB0814990 A GB 0814990A GB 0814990 D0 GB0814990 D0 GB 0814990D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0814990.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0814990.8A priority Critical patent/GB0814990D0/en
Publication of GB0814990D0 publication Critical patent/GB0814990D0/en
Priority to PCT/EP2009/060515 priority patent/WO2010018214A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/54—Spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0814990.8A 2008-08-15 2008-08-15 Compounds Ceased GB0814990D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0814990.8A GB0814990D0 (en) 2008-08-15 2008-08-15 Compounds
PCT/EP2009/060515 WO2010018214A1 (en) 2008-08-15 2009-08-13 Pyrrolidinone derivatives useful for the treatement of psychotic and neurological disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0814990.8A GB0814990D0 (en) 2008-08-15 2008-08-15 Compounds

Publications (1)

Publication Number Publication Date
GB0814990D0 true GB0814990D0 (en) 2008-09-24

Family

ID=39812138

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0814990.8A Ceased GB0814990D0 (en) 2008-08-15 2008-08-15 Compounds

Country Status (2)

Country Link
GB (1) GB0814990D0 (en)
WO (1) WO2010018214A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2012115097A1 (en) * 2011-02-21 2014-07-07 大正製薬株式会社 Glycine transporter inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200846328A (en) * 2007-02-01 2008-12-01 Glaxo Group Ltd GlyT1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
GB0701985D0 (en) * 2007-02-01 2007-03-14 Glaxo Group Ltd Compounds
JP2010517964A (en) * 2007-02-01 2010-05-27 グラクソ グループ リミテッド GlyT1 transporter inhibitors and their use in the treatment of neurological and neuropsychiatric disorders

Also Published As

Publication number Publication date
WO2010018214A1 (en) 2010-02-18

Similar Documents

Publication Publication Date Title
GB0807862D0 (en) Compounds
GB0812641D0 (en) Compounds
GB0804702D0 (en) Compounds
GB0809776D0 (en) Compounds
GB0807103D0 (en) Compounds
GB0807910D0 (en) Compounds
GB0801220D0 (en) Compounds
GB0814990D0 (en) Compounds
GB0801265D0 (en) Compounds
GB0806448D0 (en) Compounds
GB0805048D0 (en) Niovel compounds
GB0810619D0 (en) Compounds
GB0810118D0 (en) Compounds
GB0811029D0 (en) Compounds
GB0809771D0 (en) Compounds
GB0808471D0 (en) Inseticidal compounds
GB0808119D0 (en) Compounds
GB0807911D0 (en) Compounds
GB0811203D0 (en) Compounds
GB0811449D0 (en) Compounds
GB0807415D0 (en) Compounds
GB0811450D0 (en) Compounds
GB0807047D0 (en) Compounds
GB0806449D0 (en) Compounds
GB0808123D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)